Table 1.
Participant characteristics
| Mean | SD | Range | ||
| Male/Female, n | 14/22 | |||
| Type of stroke, n | ||||
| Ischemic/Hemorrhagic/Unknown | 25/10/1 | |||
| Hemiparetic side, n | ||||
| Right/Left/Bilateral | 17/17/2 | |||
| Medications | ||||
| β-blockers/ACE inhibitors/None/Both | 6/17/11/2 | |||
| Co-morbidities | ||||
| Hypertension | 25 | |||
| Cholesteremia | 12 | |||
| Diabetes mellitus | 4 | |||
| Coronary artery disease | 8 | |||
| Chronic obstructive pulmonary disease | 3 | |||
| History of smoking | 11 | |||
| Age, years | 64.6 | 14.4 | 19–90 | |
| National Institutes of Health Stroke Scale* | 2.8 | 2.3 | 0–10 | |
| Chedoke-McMaster Stroke Assessment Leg score | 5.1 | 1.0 | 4–7 | |
| Functional Independence Measure | 110.8 | 9.2 | 77–125 | |
* Data missing for 6 participants